20 reports

Medicine; ##(##): ##-##.

  • Hepatitis Treatment
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Janssen Biotech, Inc.
  • Merck & Co., Inc.
  • Market drivers

IFN has been considered a cornerstone for hepatitis treatment since its launch.

  • Hepatitis Treatment
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • PRODUCT PROFILE - PREZCOBIX

Presentation at the ##th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy, Washington, DC, US.

  • Hepatitis Treatment
  • Asia
  • Japan
  • Gilead Sciences, Inc.
  • ViiV Healthcare Ltd.
  • Gilead Sciences Enters into Licensing Agreement with Mylan Labs
  • Gilead Sciences Expands Licensing Agreement with Mylan Labs

The agreement also permit the manufacture of sofosbuvir or ledipasvir in combination with other chronic hepatitis C medicines.

  • Hepatitis Treatment
  • HIV AIDS
  • Pharmaceutical
  • India
  • Mylan Inc.
  • LICENSING AGREEMENTS
  • LICENSING AGREEMENTS

The agreement also permit the manufacture of sofosbuvir or ledipasvir in combination with other chronic hepatitis C medicines.

  • Hepatitis Treatment
  • HIV AIDS
  • United States
  • Corporate Finance
  • Gilead Sciences, Inc.

Food and Drug Administration (FDA) and European Medicines Agency (EMA) for hepatitis delta virus infection.

  • Hepatitis Treatment
  • Therapy
  • United States
  • Product Initiative
  • REPLICor Inc.

This agreement enables Mylan, MPP and BMS for access to the hepatitis C medicine daclatasvir (DCV).

  • Hepatitis Treatment
  • United States
  • Company
  • Company Financials
  • Mylan Inc.

Food and Drug Administration (FDA) and European Medicines Agency (EMA) for hepatitis delta virus infection.

  • Hepatitis
  • Hepatitis Treatment
  • United States
  • Product Initiative
  • REPLICor Inc.
  • 3. Hepatitis C - Approved Drugs Sales & Forecast
  • The six main reasons for the high price-tags on promising new HCV drugs

This agreement allows Natco to expand access to these chronic hepatitis C medicines in ## developing countries.

  • Hepatitis Treatment
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • GILEAD SCIENCES, INC.: SWOT ANALYSIS
  • GILEAD SCIENCES, INC.: COMPANY HISTORY

Gilead helped revolutionize the treatment of viral hepatitis, which affects approximately half a billion people worldwide, by providing medicines that cure chronic hepatitis C infection and manage chronic hepatitis B infection more effectively.

  • Hepatitis Treatment
  • Pharmaceutical
  • United States
  • Company
  • Gilead Sciences, Inc.
  • Gilead Sciences Enters into Licensing Agreement with Hetero Labs

The agreement also permit the manufacture of sofosbuvir or ledipasvir in combination with other chronic hepatitis C medicines.

  • Hepatitis Treatment
  • Therapy
  • India
  • United States
  • Hetero Drugs Limited
  • Clinical Trial profile. 2077 Trial Title
  • Clinical Trial
  • Drug Discovery And Development
  • Hepatitis Treatment
  • Pharmaceutical
  • World
  • GILEAD SCIENCES, INC.: SWOT ANALYSIS
  • GILEAD SCIENCES, INC.: COMPANY HISTORY

Gilead helped revolutionize the treatment of viral hepatitis, which affects approximately half a billion people worldwide, by providing medicines that cure chronic hepatitis C infection and manage chronic hepatitis B infection more effectively.

  • Hepatitis Treatment
  • Pharmaceutical
  • United States
  • Company
  • Gilead Sciences, Inc.
  • Clinical Trial profile. 1366 Trial Title
  • Clinical Trial Profile Snapshots

Alain Litwin, professor of medicine and psychiatry and behavioral sciences at Albert Einstein College of Medicine, New York.

  • Clinical Trial
  • Drug Discovery And Development
  • Hepatitis Treatment
  • World
  • Gilead Sciences, Inc.
  • 3. Hepatitis C - Approved Drugs Sales & Forecast to

This recovery followed the launches in mid-2011 of two new direct-acting Hepatitis C medicines in the US (Merck' s Victrelis and Vertex' s Incivek).

  • Hepatitis Treatment
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • Janssen Biotech, Inc.

Since this time, more than ##, ## people have received a PBS-subsidized medicine to treat chronic hepatitis C.

  • Antiviral
  • Hepatitis
  • Hepatitis Treatment
  • Research And Development
  • Bristol-Myers Squibb Company

The company provides medicines for complex health conditions such as cancer, HIV and Hepatitis C infections, multiple sclerosis and other disorders.

  • Hepatitis Treatment
  • Research And Development
  • United States
  • Product Initiative
  • Bristol-Myers Squibb Company

Please read on to explore HCV medicines and their producers, seeing how high that industry’s sales can go.

  • Antiviral
  • Hepatitis Treatment
  • Therapy
  • Market Size
  • PRICE RESISTANCE: SOVALDI CASE STUDY

COUNCIL OF THE EUROPEAN UNION (2014) HIGH PRICE OF MEDICINES AGAINST HEPATITIS C.

  • Healthcare
  • Hepatitis Treatment
  • Pharmaceutical
  • Europe
  • EFPIA company
  • REGIONAL ACCESS TO HEPATITIS C TREATMENTS VARIES IN SPAIN
  • CREATIVE TAXATION MAY BE USED TO MITIGATE BUDGETARY IMPACT OF PAYING FOR NEW HEPATITIS C THERAPIES
  • Hepatitis Treatment
  • Europe
  • United States
  • Gilead Sciences, Inc.
  • Humana Inc.